CompletedNot Applicable

Tranexamic Acid as an Intervention in Abruptio Placenta

Iraq116 participantsStarted 2023-01-10

Plain-language summary

Abruptio placenta is one of the common causes of antepartum haemorrhage which is more common in the second half of pregnancy and causes a high maternal and neonatal morbidity and mortality

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 24 weeks gestation and more * Stable hemodynamically * Accepted to participate Exclusion Criteria: * Hypersensitivity to tranexamic acid * Defective color vision * History of venous thromboembolism * Pre-existing medical conditions that could affect pregnancy outcomes (diabetes mellitus, hypertension, renal disease) * Smoker * Refused to participate in the trial

What they're measuring

Hemostasis

Timeframe: Up to time of delivery

Gestational age

Timeframe: at time of delivery

Favorable perinatal outcome

Timeframe: up to 7 days post partum

Trial details

NCT IDNCT05840471

SponsorHawler Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-02

View on ClinicalTrials.gov More Vaginal Bleeding trials